Johnson and Johnson Recall

From Pharmacy Drug Guide

Jump to: navigation, search

Johnson & Johnson is a multi-national pharmaceutical, medical devices and consumer packaged goods manufacturer based in the United States. It has high brand recognition for a variety of over-the-counter (OTC) medications and first aid supplies, including Johnson's line of baby products, Band-Aid brand bandages, Tylenol analgesic medications, Neutrogena skin care and beauty products, Clean & Clear facial wash, and Acuvue contact lenses.[1] Ranked number one in Barron's 2008 listing of companies most prized and respected by investors, Johnson & Johnson suffered multiple setbacks in 2010 for issues ranging from plant quality control to charges of illegal marketing practices.[2] [3]



Flickr: Guerrilla Futures
Founded 1886[4]
Location New Brunswick, New Jersey[5]
Telephone 732-524-0400[5]
Areas served Global
Products Pharmaceuticals, health care products, medical devices and prosthetics, toiletries, soaps, shampoos[6]
Disclaimer The information provided by PharmacyDrugGuide.com is not a substitute for professional medical advice, diagnosis, or treatment. Do not take any action based on the information on this page without consulting a physician.
 

Contents

Johnson & Johnson 2011 Motrin Recall

On December 21, 2011, a wholesale-level recall was issued for 59 lots of Motrin IB. Consumers are not being advised to return Motrin IB because no adverse effects are expected. As these lots of Motrin approach their expiration date, the pills are not dissolving as expected and it may take longer for the medication to begin to work. Consumers may have "a delay in experiencing relief." Motrin IB 24 coated tablets, Motrin IB 24 coated caplets, and Motrin IB 24+6 coated caplets are affected.[7] [8]

Johnson & Johnson 2011 Tylenol Recall

On August 15, 2011, a voluntary recall was issued for Tylenol Cold Multi-Symptom Nighttime Rapid Release Gelcaps sold in the United States and Puerto Rico. Although no adverse effects have been reported and none are deemed likely, certain lots have higher-than-normal levels of a substance called Chlorpheniramine Ammonio Acetate (CPAA). The affected products are: Tylenol Cold Multi-Symptom Rapid Release Gelcaps Day/Night 36+24 RR Gelcaps, lot numbers BBF001, BCF060, BCF079; Tylenol Cold Multi-Symptom Rapid Release Gels Day/Night 12+8 RR Gelcaps, lot numbers AMF034, BAF005, BAF027, BCF080; and Tylenol Cold Multi-Symptom Nighttime Rapid Release Gels 24 RR Gelcaps, lot numbers AMA277, APA059, APA162, ASA025, APA237, ASA072, ASA208, BAA008.[9] Johnson and Johnson recommends calling 1-888-222-6036 for more recall information.[10]

Johnson and Johnson 2011 Risperdal and Risperadone Recall

In June 2011, Johnson and Johnson recalled the antipsychotic medication Risperdal for a foul odor. The generic version of the drug, risperadone, was also recalled. The odor was linked to a nontoxic chemical called TBA, which came from a preservative contained in wooden storage pallets. There have been no adverse reactions reported other than the unpleasant smell. 16,000 bottles of Risperdal and 24,000 bottles of risperidone were recalled from lot numbers 0GG904 and OlG175.

Johnson and Johnson 2011 Sudafed Recall

McNeil Consumer Healthcare is recalling nine product lots of Sudafed 24 Hour, Pseudoephedrine HCl, Extended – Release Tablets, 10 count, 240 mg each due to a typographical error in the Directions section on the label, which incorrectly repeated the word "not," i.e., "do not not divide, crush, chew, or dissolve the tablet." To date there have been no reports of adverse events due to the labeling error. Affected lot numbers are: 1004651, 1004652, 1005870, 1005874, 1008467, 1008468, 1009532, 1010850, 1013065.[11]

Johnson and Johnson 2011 Simponi Recall

Two lots of injection pens preloaded with rheumatoid-arthritis drug Simponi were recalled on February 18, 2011 because they did not deliver a full dose of the drug.[12] Approximately 900 units in Lot 09D071.AC were shipped within the United States. The other units were distributed in Germany. A temporary shortage of Simponi injection pens is expected as a result of the recall.

Johnson and Johnson 2010 Children's Product Recalls

McNeil Consumer Healthcare, a Johnson & Johnson subsidiary, initiated a recall of 43 OTC children's medications on April 30, 2010 that included Tylenol, Tylenol Plus, Motrin, Zyrtec and Benadryl.[13] The reason provided for the recall was Fort Washington, Pennsylvania facility products "may not fully meet the required manufacturing specifications." Specifics included products containing a "higher concentration of active ingredients" or other manufacturing defects, and included shipments within the United States as well as shipments to Canada, Dominican Republic, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad and Tobago, the United Arab Emirates, Kuwait and Fiji. The initial recall was followed by additional recalls. A dedicated website was established by Johnson & Johnson to address the children's product recalls.[14]

Johnson and Johnson 2010 DePuy Hip Implant Recall

On August 24, 2010, DePuy, a Johnson & Johnson company, initiated a recall for the ASR XL Acetabular metal-on-metal hip replacement system when it was determined that the product's five-year failure rate was approximately 13 percent, or 1 in 8 patients. The FDA has received approximately 400 complaints from patients who received ASR hip replacements since 2008.[15]

Johnson and Johnson Executives Grilled by Congress

Johnson & Johnson executives testified before Congress after a string of recalls that left both the company and the FDA under scrutiny.

Johnson and Johnson 1982 Chicago Tylenol Murders

On September 29, 1982, a "Tylenol scare" began in metropolitan Chicago, after the first of seven died as a result of ingesting Extra Strength Tylenol that had been laced with cyanide.[16] Johnson & Johnson recalled 31 million bottles of capsules, making this Tylenol recall one of the first major recalls. As a result, widespread reforms were initiated in the packaging of over-the-counter substances and changes made to federal anti-tampering laws. The case remains unsolved.

Also see: Tylenol Recall, Motrin Recall, Depuy Hip Implant Recall, Benadryl Recall, Mylotarg Recall, Miralax Recall, Lipitor Recall, Simponi, NIH, FDA

References

  1. ↑ http://www.jnj.com/connect/healthcare-products/?flash=true
  2. ↑ http://online.barrons.com/article/SB122065360919305361.html
  3. ↑ http://www.washingtonpost.com/wp-dyn/content/article/2010/01/15/AR2010011503903.html
  4. ↑ http://www.jnj.com/wps/wcm/connect/620579804fdd4a0e97a5b753d1df9354/student-information-kit.pdf?MOD=AJPERES
  5. ↑ 5.0 5.1 https://secure-www.jnj.com/wps/wcm/jsp/contactUs.jsp
  6. ↑ http://www.jnj.com/connect/healthcare-products/?flash=true
  7. ↑ http://www.motrin.com/news/7
  8. ↑ http://www.latimes.com/business/la-fi-motrin-recall-20111222,0,3394039.story
  9. ↑ http://www.tylenol.com/page2.jhtml?id=tylenol/news/subp_tylenol_recall_7.inc
  10. ↑ http://www.jnj.com/connect/healthcare-products/consumer/
  11. ↑ http://www.sudafed.com/?news=true
  12. ↑ http://www.reuters.com/article/2011/02/18/jandj-recall-idUSN1813987920110218
  13. ↑ http://www.fda.gov/safety/recalls/ucm210443.htm
  14. ↑ http://www.mcneilproductrecall.com/
  15. ↑ http://asrrecall.depuy.com/asr-hip-replacement-recall
  16. ↑ http://www.nytimes.com/2002/03/23/your-money/23iht-mjj_ed3_.html?pagewanted=1
Retrieved from "http://www.pharmacydrugguide.com/Johnson_and_Johnson_Recall"



Personal tools